Exposure-response relationship during vedolizumab induction therapy in adults with ulcerative colitis

被引：0
|
作者：
Rosario, M. [1 ]
French, J. [2 ]
Dirks, N. [2 ]
Milton, A. [1 ]
Fox, I. [1 ]
Gastonguay, M. [2 ]
机构：
[1] Takeda Pharmaceut Int Co, Clin Pharmacol, Cambridge, MA USA
[2] Metrum Res Grp LLC, Biotechnol, Tariffville, CT USA
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P489
引用
收藏
页码：S270 / S271
页数：3
相关论文
共 50 条
  • [21] Pharmacokinetics and Exposure-Response Relationships of Ustekinumab in Patients With Ulcerative Colitis: Results From the UNIFI Induction and Maintenance Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen
    O'Brien, Christopher
    Szapary, Philippe
    Zhang, Hongyan
    Johanns, Jewel
    Leong, Rupert W. L.
    Hisamatsu, Tadakazu
    Van Assche, Gert
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S481 - S482
  • [22] Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
    Feagan, Brian G.
    Rubin, David T.
    Danese, Silvio
    Vermeire, Severine
    Abhyankar, Brihad
    Sankoh, Serap
    James, Alexandra
    Smyth, Michael
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (02) : 229 - +
  • [23] Predictive transcriptional signatures associated to vedolizumab therapy response in patients with ulcerative colitis
    Gomez, M. Camba
    Arosa, L.
    Calvino-Suarez, C.
    Baston-Rey, I.
    Ferreiro-Iglesias, R.
    Porto, M.
    Nieto, L.
    Dominguez-Munoz, J. E.
    Barreiro-De Acosta, M.
    Conde-Aranda, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 818 - 819
  • [24] MUCOSAL EOSINOPHILS AS MARKERS OF POST- INDUCTION VEDOLIZUMAB RESPONSE IN PAEDIATRIC ULCERATIVE COLITIS
    Musto, F.
    Ranalli, M.
    Giordano, C.
    Bianchi, E.
    Veraldi, S.
    Oliva, S.
    D'Arcangelo, G.
    Aloi, M.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S126 - S126
  • [25] Transcriptional biomarkers for vedolizumab therapy response in patients with moderate to severe Ulcerative Colitis
    Arosa Garcia, L.
    Camba-Gomez, M.
    Calvino-Suarez, C.
    Baston-Rey, I.
    Ferreiro-Iglesias, R.
    Porto, M.
    Nieto-Garcia, L.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    Conde-Aranda, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I147 - I147
  • [26] Mucosal eosinophils as markers of post-induction vedolizumab response in paediatric Ulcerative Colitis
    Musto, F.
    Ranalli, M.
    Giordano, C.
    Bianchi, E.
    Veraldi, S.
    Oliva, S.
    D'Arcangelo, G.
    Aloi, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 752 - 753
  • [27] Pharmacokinetics and exposure-response analyses of upadacitinib in patients with moderate to severe ulcerative colitis - Analyses of induction and maintenance clinical trials
    Ponce-Bobadilla, A. V.
    Stodtmann, S.
    Eckert, D.
    Zhou, W.
    Liu, W.
    Mohamed, M. E.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I355 - I357
  • [28] Tofacitinib Plasma Concentration Monitoring Is Not Needed for Optimization of Induction Therapy in Moderate to Severe Ulcerative Colitis: Results of Pooled Exposure-Response Analyses of Phase 3 Induction Studies
    Mukherjee, Arnab
    Tsuchiwata, Shinichi
    Deng, Chenhui
    Vong, Camille
    Xie, Rujia
    Martin, Steven W.
    Yu, Dahong
    Woodworth, Deborah A.
    Niezychowski, Wojciech
    Su, Chinyu
    GASTROENTEROLOGY, 2016, 150 (04) : S774 - S774
  • [29] Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
    Pouillon, Lieven
    Rousseau, Helene
    Busby-Venner, Helene
    Bittencourt, Marcelo De Carvalho
    Choukour, Myriam
    Gauchotte, Guillaume
    Zallot, Camille
    Danese, Silvio
    Baumann, Cedric
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (08): : 970 - 975
  • [30] Pharmacokinetics and exposure-response analyses of upadacitinib in patients with moderate to severe ulcerative colitis - Analyses of induction and maintenance clinical trials
    Ponce-Bobadilla, A. V.
    Stodtmann, S.
    Eckert, D.
    Zhou, W.
    Liu, W.
    Mohamed, M. E.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I355 - I357
12345